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Abstract
X chromosome inactivation (XCI) is a dosage compensation mechanism essential for embryonic development and cell
physiology. Human embryonic stem cells (hESCs) derived from inner cell mass (ICM) of blastocyst stage embryos have been
used as a model system to understand XCI initiation and maintenance. Previous studies of undifferentiated female hESCs at
intermediate passages have shown three possible states of XCI; 1) cells in a pre-XCI state, 2) cells that already exhibit XCI, or
3) cells that never undergo XCI even upon differentiation. In this study, XCI status was assayed in ten female hESC lines
between passage 5 and 15 to determine whether XCI variations occur in early passages of hESCs. Our results show that
three different states of XCI already exist in the early passages of hESC. In addition, we observe one cell line with skewed XCI
and preferential expression of X-linked genes from the paternal allele, while another cell line exhibits random XCI. Skewed
XCI in undifferentiated hESCs may be due to clonal selection in culture instead of non-random XCI in ICM cells. We also
found that XIST promoter methylation is correlated with silencing of XIST transcripts in early passages of hESCs, even in the
pre-XCI state. In conclusion, XCI variations already take place in early passages of hESCs, which may be a consequence of in
vitro culture selection during the derivation process. Nevertheless, we cannot rule out the possibility that XCI variations in
hESCs may reflect heterogeneous XCI states in ICM cells that stochastically give rise to hESCs.
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Introduction
Human embryonic stem cells (hESCs) are an invaluable tool for
regenerative medicine and a model for early human embryogen-
esis [1]. Numerous studies in the past ten years have described the
capacity of hESCs to differentiate into specialized cells from the
three germ layers [2]. In certain instances, in vitro differentiated
hESCs can be integrated and become functional in transplantation
experiments [3,4]. Due to the wide applications of hESCs, there
have been increasing demands for more newly derived hESC lines.
This interest allows comparison of different properties among
various hESC lines and can potentially create a gold standard for
the characterization of hESC lines. Therefore, efforts have been
made to generate gene expression and epigenetic profiles for
hESCs [5,6,7,8,9]. Although it seems that the gene expression
profile is quite consistent for all hESC lines, the epigenetic status
varies significantly [6,10]. For example, XIST gene expression
varies among different hESC lines and even within the same cell
line [5,11,12,13].
In mice, Xist is known to play a major role in X chromosome
inactivation (XCI) during female mammalian embryogenesis. In
this process, genetic and epigenetic events, beginning with
expression of Xist, allow equal expression from the X chromosome
in male and female cells. In the mouse model system, XCI occurs
in two waves during embryogenesis. At the two-cell stage, the
imprinted paternal X chromosome is exclusively inactivated.
During blastocyst formation, cells in the inner cell mass (ICM)
reactivate the paternal X chromosome whereas the trophectoderm
and primitive endoderm retain their imprinted XCI. Upon
differentiation, the second wave of XCI occurs in a random
fashion; thus each somatic cell will possess either maternal or
paternal active X chromosome (reviewed in ref. [14]). Further-
more, it was shown that mouse ESCs (mESCs) and induced
pluripotent stem cells (iPSCs) recapitulate random XCI upon
differentiation [15,16]. Due to prominent developmental differ-
ences between mouse and human, XCI patterns between the two
species are not well conserved. Indeed, both random and skewed
XCI patterns are observed in human extra-embryonic tissue
(placenta), but not mouse extra-embryonic tissue, which show
exclusive paternal X chromosome inactivation [17]. Therefore, an
assessment of the XCI during early human embryogenesis is still
needed.
A recent study in pre-implantation human embryos reported
that XIST transcript accumulation on the X chromosome is
initiated in the eight-cell stage embryo with full establishment of
XIST clouds in the blastocyst stage [18]. However, the identity of
the cells showing XIST accumulation is not obvious due to three
distinct cell populations found in the blastocyst stage embryos,
namely trophectoderm, primitive endoderm and ICM. Further-
more, the XCI pattern (skewed or random) is still unclear.
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XCI in human pre-implantation embryos still remain to be
resolved.
Since differentiation of hESCs can be used to model human
embryogenesis in vitro, they are examined for the initiation and
maintenance of XCI. Several research groups including ours
reported that XCI in hESCs, unlike their rodent counterparts, is
unstable and prone to changes during culture [5,10,13,19,20].
Recent in depth XCI studies with several hESC lines described
three different states of XCI in these cells [13,19,20] (reviewed by
Dvash and Fan, 2009 [21]). The first or ‘‘naı ¨ve’’ state refers to
undifferentiated hESCs that possess two active X chromosomes.
However, upon differentiation, they acquire one inactivated X
chromosome. The second or intermediate state refers to hESCs
that show XCI markers in both undifferentiated and differenti-
ated states. The third state describes hESCs that do not show any
XCI markers in both undifferentiated and differentiated states.
Interestingly, it has been suggested that hESCs progress gradually
during culture from the first ‘‘naı ¨ve’’ state, to the second stage
exhibiting XCI, then to the third state where all XCI marks are
irreversibly lost [19] [21]. Furthermore, there is a correlation
between the inability to express XCI marks and biallelic
methylation pattern on the XIST promoter [13]. Importantly,
all the above mentioned studies used mid to late passage hESCs
(,p20–p100), that have been exposed to long term culture
effects.
It is therefore better to evaluate the status of XCI in early
passages of undifferentiated hESCs that have been minimally
exposed to culture effects. Hereby we report the status of XCI in
ten lines of female hESC at the earliest passages available. Our
results indicate that the three distinct states of XCI can be
observed even in minimally passaged hESCs. In addition, we
investigated the pattern of XCI in two cell lines- one showed
random XCI reminiscent of mESCs, while the other showed non-
random XCI. Consistently, we found that the methylation pattern
of the XIST promoter is tightly associated with silencing of XIST
expression in early passages of female hESCs.
Results
XIST expression analysis in CSES cell lines at early
passages
Recent studies have identified three distinct states of XCI in a
variety of female hESCs [12,13,19]. These studies have also
implied that these three XCI states are the consequence of long
term culture conditions. We hypothesized that by using early
passage hESCs, which have minimal exposure to culture effects,
we may be able to better evaluate XCI status in the derivation of
hESCs. For this purpose, we used newly derived CSES cell lines
[22] at the earliest available stage such as passage five (p5) for some
of the cell lines to study XCI.
Relative expression levels of XIST were assessed in all ten female
cell lines (CSES1, 2, 3, 5, 6, 7, 8, 10, 11 and 14) by using real-time
PCR analysis. In the undifferentiated state, four of the examined
cell lines (CSES 1, 8, 10 and 11) expressed XIST while all the other
lines did not show any XIST expression (Fig 1A). We then asked
whether XIST expression can be induced in hESCs that do not
express XIST upon teratoma differentiation. Consistent with
previous findings [13] all cell lines that expressed XIST in the
undifferentiated state were able to maintain and even up-regulate
XIST expression upon differentiation. Interestingly, two of the cell
lines (CSES2 and CSES7) that did not express XIST in the
undifferentiated state were able to induce XIST expression upon
differentiation, though at a lower level (Fig 1B). However, four cell
lines (CSES3, CSES5, CSES6 and CSES14) did not express XIST
both at the undifferentiated and differentiated state. These results
clearly demonstrate that three different states of XCI exist in
hESCs even after a short culture period. We conclude that CSES2
and CSES7 cells are in the ‘‘naı ¨ve’’ state, showing XIST expression
only upon differentiation; CSES1, 8, 10 and 11 cells are in the
intermediate state, showing XIST expression at the undifferenti-
ated state and further induction upon differentiation; and CSES 3,
5, 6, 14 cells are in the third ‘‘culture affected’’ state, showing no
XIST expression regardless of undifferentiated or differentiated
conditions.
It has been shown that XCI initiation correlates with low levels
of pluripotency related factors in mouse ES cells [23]. To exclude
the possibility that XIST expression in undifferentiated hESCs
occurs due to differentiation in culture, we analyzed pluripotency
gene expression along with XIST expression by using the ABI
human stem cell pluripotency low density array. Delta Ct values
were calculated for each gene compared to the control gene, beta
actin (Fig. 1C, D). Brown-Forsthye test shows that all pluripotency
genes are expressed with small variance between different cell lines
analyzed (p=0.27) (Fig. 1C), whereas XIST expression varied
significantly (p=2.2610
217) (Fig. 1D). These results were
supported by our observation of simultaneous appearance of
XCI markers and undifferentiated stem cell markers such as
OCT4 by immunostaining (Fig. 2G).
To visualize XCI states at a single cell resolution, we assayed for
XIST RNA coating of the inactive X (Xi) by using FISH analysis
or enrichment of histone 3 lysine 27 tri-methylation (H3K27me3)
by immunocytochemistry [24,25]. Consistent with XIST expres-
sion, cell lines such as CSES1 showed punctate staining for
H3K27me3 on the Xi (Fig. 2A). XIST RNA coating was also
identified on one of the X chromosomes in virtually all of the cells
(Fig. 2D). In contrast, cell lines such as CSES3 lack both
H3K27me3 punctate staining and XIST RNA coating of the Xi
(Fig. 2B, E). Interestingly, CSES3 lacks XCI markers at early
passages (p6) (Fig. 2C, F) and upon long term culture (p31) (Fig. 2B,
E). In addition, these cells lack the capability to induce XCI upon
teratoma formation (Fig 1 B).
Low level of XIST expression as seen in CSES10 (Fig. 1A, D)
can be explained either by uniformly low XIST expression in the
entire cell population or by high expression from a small subset of
cells. In order to distinguish between the two possibilities, we
calculated the percentage of cells exhibiting punctate H3K27me3
staining. Indeed, all cell lines that do not express XIST also do not
show any H3K27me3 punctate staining. However, in interme-
diate state (state II) cells, we observed a significant number of cells
with punctate staining for H3K27me3 (Fig. S1). Therefore, low
level of XIST expression in CSES10 p15 cells correlates with a
lower number of H3K27me3 positive cells, indicating a low
number of XIST expressing cells. Furthermore, all H3K27me3
positive cells were positively stained for OCT4 (data not shown),
which again suggests that XCI can occur in undifferentiated
hESCs.
Finally, we also observed the transition from the XIST
+ to the
XIST
2 XCI state in subcultures of early passage hESCs. In
CSES8, H3K27me3 punctate staining can be detected at a high
percentage in p8 (n=257, 87%); however the number of
positively-stained cells was significantly reduced by p17 (n=403,
48%). In parallel, XIST mRNA expression was dramatically
reduced in p17 CSES8 hESCs (Fig 2G).
Skewed versus random XCI pattern in CSES cell lines
During mouse embryogenesis, imprinted XCI of the paternal X
chromosome occurs prior to the blastocyst formation whereas
XCI in Early Passages of hESCs
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we observed non-random XCI in later passages of female hESC
lines [13]. Given that the XCI states seems to be affected by
culture and that culture pressure could result in clonal selection,
we were curious to see whether XCI is random or skewed in early
passages of hESCs.
Figure 1. XIST expression in CSES cell lines. (A) XIST relative expression levels in CSES undifferentiated cells. (B) XIST relative expression levels in
teratomas derived from CSES cells. (C) Pluripotency gene expression by Delta Ct in CSES cell lines in different passages as well as in H1 (male) cell line.
(D) XIST expression by Delta Ct in all CSES cell lines analyzed compared to H1 (male) cell line. Significant values (p,0.01) are marked by asterisks.
doi:10.1371/journal.pone.0011330.g001
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and CSES8, because both showed XCI markers. In order to verify
the parental origin of the active X chromosome, we used maternal
DNA that was extracted from granulosa cells, which are somatic
cells that surround the oocyte during maturation. These cells are
normally removed at the time of egg retrieval during IVF
procedure in order to expose the oocyte surface for fertilization.
Frozen granulosa cells for CSES1 and CSES8 were used for DNA
extraction. Following DNA amplification these samples were
hybridized to Affymetrix SNP array (250k Sty) side by side with
the corresponding hESC DNA. The results from this analysis
enabled us to choose SNPs within X-linked genes that were
identified as heterozygous in the hESC lines and homozygous in
the maternal DNA.
In order to verify the maternity of the granulosa DNA sample
with the corresponding hESC sample, we performed identical by
state (IBS) analysis to show that our samples are genetically
related. For instance, comparison of CSES1 and its corresponding
maternal sample showed that in 71.7% of the SNPs both alleles
are shared (IBS=2) and in 28% of the SNPs one of the alleles is
shared (IBS=1). This indicates that 99.7% of SNPs show at least
one allele shared between the samples. Overall 85.7% of SNPs are
shared between CSES1 and its maternal sample. This indicates
close genetic relationship between the two samples (Fig. S2). In
order to perform SNP expression analysis, we selected genes that
show moderate to high expression in undifferentiated hESCs.
Consequently, we analyzed the expression of seven SNPs for
CSES1 and nine SNPs for CSES8 along the X chromosome
(Table 1, 2, Fig. S3, S4).
Our results indicate discrepancies between the two hESC lines
with regard to the pattern of XCI. In the CSES8 cell line at both
p5 and p14, we consistently observed bi-allelic expression of X-
Figure 2. Stability of XCI markers in CSES lines. (A) CSES1 shows positive punctate staining for H3K27me3 (indicated by the arrow heads).
CSES3 cells do not show punctate staining pattern for H3K27me3 in (B) late or (C) early passages. (D) Shown is XIST RNA coating of Xi by FISH in CSES1
cell line (indicated by the arrow heads). (E) CSES3 lack XIST RNA coating of Xi as indicated by FISH analysis. (F) CSES3 is positively stained for OCT4
(green) at p6. (G) CSES8 at p8 shows H3K27me3 punctate staining along with OCT4 staining; however, the relative expression of XIST is reduced in
this cell line at p14. This observation is supported by a decrease in the cell population with H3K27me3 punctae in p17 (48% of the cells).
doi:10.1371/journal.pone.0011330.g002
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other hand, CSES1 at p5 showed preferential expression of the
paternal allele suggesting skewed XCI with six out seven X-linked
genes exhibiting mono-allelic expression from the paternal X.
Theoretically, the probability of having maternal or paternal allele
expressed per SNP is 50%. According to binomial distribution
B(x=6; n=7, p=0.5), the cumulative probability of getting as
many as six out of seven SNPs with paternal expression is 0.0625.
Since this probability is very small, it argues against the hypothesis
of random XCI in this case. Therefore, the preferential expression
from the paternal allele is due to skewed maternal X inactivation.
Moreover, upon prolonged culture of CSES1 cell line, we observe
partial reactivation of the second allele that coincides with the loss
of XIST expression at later passages. For example, rs41537046
expressed only the paternal allele (A) at p5, whereas both paternal
and maternal alleles are expressed (A/G) by p14 (Table 1 and Fig.
S3). This is consistent with our previous observation that loss of
XIST expression would lead to partial reactivation of a portion of
previously silenced genes in Xi [13].
XIST promoter methylation status correlates with the
three different states of XCI in hESCs
The variability of XCI status in early passages may indicate
epigenetic modifications of the XIST promoter that occur either
prior or subsequent to the hESCs derivation process. Indeed, it
was previously suggested that XIST promoter methylation pattern
is correlated with the XCI status of the cells [13,21]. Consistently,
our analysis demonstrates that CSES1 at p11 expresses XCI
markers and have ,50% methylation at the XIST promoter
(Fig. 3). This result is consistent with the observation that one of
the XIST alleles in these cells expresses XIST in the undifferen-
tiated state as well as upon teratomas differentiation. In addition,
the XIST promoter shows ,90% methylation in later passages of
CSES8 (p28) consistent with silencing of both XIST alleles and the
loss of XCI markers upon long-term culture (data not shown). We
also observed 70–96% methylation in the XIST promoter of
CSES3 and CSES5 (Fig. 3), even in early passages (p11 and p12
respectively). This is correlated with the inability of these cell lines
to induce XCI in either undifferentiated state or upon teratomas
differentiation (Fig. 1B). Interestingly, both CSES2 and CSES7,
which exhibit XCI only upon differentiation, also showed 80–87%
methylation of the XIST promoter in early passages (p12 and p10
respectively) (Fig. 1B and Fig. S5). This observation suggests that
DNA methylation is also involved in repression of XIST gene
expression in the pre-XCI state.
Discussion
In this study, we attempted to minimize the in vitro culture
effects by using hESCs at the earliest available time. It has been
shown that long term culture can contribute to the variation in
XCI status of hESCs [13,19,20]. We found that early passage cell
lines already exhibit various XCI states similar to cell lines after
prolonged culture. While it is formally possible that culture
variations in the first few weeks of hESC derivation and
expansion may yield XCI variation, we cannot rule out the
alternative possibility that XCI variations may reflect innate












rs5914796 Xp11.21 56807583 DKFZp686L07201 A/T T/T A A
rs4828327 Xq21.1 84236784 SATL1 A/C C/C A -
rs6620161 Xq21.33 96027150 DIHPA2 A/G G/G A/G A/G
rs2428212 Xq24 118985598 UPF3B A/G G/G A A
rs6641482 Xq28 147887801 AFF2 G/A A/A G -
rs41537046 Xq26.2 132470683 GPC4 A/G G/G A A/G
rs895744 Xq28 153998985 BRCC3 G/T T/T G -
doi:10.1371/journal.pone.0011330.t001












rs3747276 Xp22.11 21985464 SMS A/G G/G A/G A/G
rs6628886 Xp21.1 34654777 TMEM47 A/G G/G A/G A/G
rs6625472 Xq13.1 68739542 TMEM28 A/G G/G A/G A/G
rs479640 Xq13.2 73668829 SLC16A2 C/T T/T C/T C/T
rs717689 Xq21.1 77379935 PGK1 A/G G/G A/G A/G
rs1204399 Xq22.1 99886830 TSPAN6 A/G G/G A/G A/G
rs2294504 Xq23 109552667 AMMECR1 C/T T/T C/T C/T
rs42890 Xq24 119578513 LAPM2 T/G G/G T/G T/G
rs5977910 Xq26.2 132901293 GPC3 T/G T/T T/G T/G
doi:10.1371/journal.pone.0011330.t002
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embryo. This hypothesis is supported by a study on cultured
mouse ICM cells reporting that these cells can undertake different
paths- such as differentiation to epiblast, reversion into pre-
blastocyst embryonic cell stage or selective expansion of a distinct
subpopulation- and therefore differ in their XCI status [30]. Of
note, mouse EpiSCs exhibit XCI as they are derived from a later
stage of mouse embryogenesis and resemble the morphology and
the expression patterns of the hESCs [28,29,32]. Thus, it is
formally possible that at the time of the hESCs derivation, some
of ICM cells have already progressed to a more committed state
and already initiate XCI [24], whereas other ICM cells are still at
a pre-XCI stage that eventually give rise of hESCs in the ‘‘naı ¨ve’’
pre-XCI state.
Here we show that variations of XCI are already present from
early passage (p5) to later passage (p14) of the same cell line
(CSES8), supporting the notion that XCI is highly affected by
culture conditions [13], even at the earliest stages of culturing.
Very recently, it was demonstrated that derivation of hESCs in
physiological oxygen concentration (5%) allows establishment of
hESC in a naı ¨ve pre-XCI state, with two active X chromosome
[31]. Irreversible XCI occurs when the naı ¨ve female hESCs are
cultured in atmospheric oxygen concentration (20%) conditions.
This is consistent with the previous notions that female hESCs can
switch from a pre-XCI state to established XCI status upon culture
selection.
Concerning the pattern of XCI in hESCs at the early passages,
our SNP analysis revealed random XCI for one line of hESCs
(CSES8) while skewed XCI for the other cell line (CSES1) with
preferential expression from the paternal X chromosome. Skewed
XCI is known to happen during mouse embryogenesis at the two
cell stage until the blastocyst stage when the inactive paternal X
becomes reactivated. In this case, the inactivation is imprinted and
the paternal X chromosome is inactivated. In hESCs, methylation
specific analysis of a polymorphic tri-nucleotide repeat at the
HUMARA gene show three out of four hESC lines possess skewed
XCI while one has a random pattern of inactivation [33].
Interestingly, this research group also analyzed a triploid (3PN)
hESC line and showed a progression from a random XCI to a
skewed pattern of XCI. Similarly, transition of naı ¨ve hESCs,
possessing two active X chromosomes under physiological oxygen
concentrations to atmospheric oxygen concentrations also result in
skewed XCI [31]. We show that in CSES1 cells the maternal X
chromosome is inactivated. Our observations for CSES1 cell line
combined with the observation from Liu et al. [33] and Lengner et
al. [31] suggest that culture selection during hESC culture may
results in skewed XCI as reported [13,31,33].
The mechanism underlying the initiation and loss of XCI
markers in hESCs is largely unknown. It is known that Xist
promoter is 50% methylated in undifferentiated female mESCs
[34]. However, the methylation status of human XIST promoter in
the pre-XCI state is previously unknown. In order to gain some
insight into this mechanism, we analyzed the methylation patterns
of XIST promoter in early passages of hESCs. Cells that show XCI
markers both prior and post differentiation have approximately
50% methylation of the XIST promoter as expected. We also
observe gain of methylation in the XIST promoter region upon
further passages, which is also associated with loss of XIST
expression and other XCI markers in the case of CESE8 hESCs.
Here we show that hypermethylation of the XIST promoter is also
observed in short term culture (CSES3 and CSES5). This
correlates with the inability of these cells to initiate XCI upon
differentiation. Surprisingly, cell lines such as CSES2 and CSES7
were able to initiate XCI upon differentiation but showed relative
high methylation on the XIST promoter in the undifferentiated
state, consistent with reports by Lengner et al. [31] for their hESCs
in the pre-XCI state. The ability of these two CSES cell lines to
initiate XIST expression upon differentiation suggests two
possibilities: (i) there might be an additional XCI state in hESC
where hypermethylation of the XIST promoter is reversed and
consequently XIST transcript is expressed, or (ii) only a minority of
the cells within the teratomas express XIST whereas the majority
of cells do not express XIST.
In this study, we propose that XCI occurs in undifferentiated
hESC in a random manner and the observations of skewed XCI
are probably a result of a clonal selection occurring in hESC
culture. It was recently shown that mouse induced pluripotent cells
(miPSC) recapitulate XCI patterns of mESCs [16]. Therefore,
analysis of human iPSCs may elucidate whether these cells can
reactivate both X chromosomes and maintain their active state in
the undifferentiated state, or whether XCI occur in these cells in
the undifferentiated state as in hESCs. Moreover, previous reports
have demonstrated the involvement of pluripotency factors in the
initiation of XCI in mESCs [23]. Since hESCs and mEpiSCs
seems to represent a more committed derivative of the ICM it is
possible that a different set or levels of transcription factors present
in these cells are responsible for the different patterns of XCI
between mouse and human ESCs.
Figure 3. XIST promoter methylation analysis in CSES cell lines. Schematic of XIST promoter CpG sites and bisulfite sequencing results of the
corresponding CpG sites in the XIST promoter in each cell line. Open circle represents unmethylated CpG site and closed circle represents methylated
CpG site.
doi:10.1371/journal.pone.0011330.g003
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indicates either rapid epigenetic culture effect or the potential
heterogeneity of the original ICM cells. It seems that the cells, even
in early passages, tend to undergo XCI and later on lose the XCI
markers. Thus, XCI process is highly affected by culture
conditions and inactivation of one of the X chromosomes may
provide an advantage in the current culture condition. We propose
that a careful re-examination of XCI status in human ICM will
shed light on the status and pattern of XCI in these cells. It is
known that normal XCI is critical in the embryonic development
[35] and inappropriate XCI is involved in different pathologies
such as cancer [36]. Therefore, routine evaluation of XCI status
should be a standard procedure for any pluripotent cells, including
iPSCs, when they are applied to regenerative medicine.
Materials and Methods
Ethic statement
This research was approved by UCLA Embryonic stem cells
research oversight (ESCRO) committee.
Human ESC culture and differentiation
Cedars Sinai Embryonic Stem cell lines (CSES) were derived as
described [22] and were cultured on mouse embryonic fibroblasts
(MEF) in hESC medium [2] supplemented with 30ng/ml bFGF
until cell line establishment. Upon establishment bFGF concen-
tration was reduced to 5ng/ml. Manual passaging method was
applied until a stable cell line was established (normally between
p4 to p8), and thereafter enzymatic transfers were done either by
using Trypsin/EDTA or collagenase type IV [2]. Cells were
allowed to undergo in vivo differentiation by injection of 5610
6
cells under the kidney capsule of Nude mice. A month after
injection, the mice were euthanized and teratomas were removed
for RNA extraction. The care of the animals was in accordance
with the institutional guidelines, as approved by Cedars Sinai
Medical Center Institutional Animal Care and Use Committee,
according to protocol 2182. In vitro differentiation was carried out
on matrigel coated plates and the cells were cultured in hESC
medium without bFGF supplemented with 2 mM retinoic acid
(Sigma) for seven days.
RNA extraction and real time polymerase chain reaction
analysis
Total RNA was extracted using RNeasy mini kit (Qiagen,
Valencia, CA http://www1.qiagen.com) and was treated with
DNase I as described in the RNeasy mini kit protocol. 1 mgo f
DNase treated RNA was subjected to reverse transcription by
iScript cDNA synthesis kit (Bio-Rad, Hercules, CA http://www.
bio-rad.com). cDNA was either subjected to PCR amplification for
SNP analysis as described below or for real-time PCR that was
carried out with Bio-Rad iCycler using IQ
TM SYBRH green
supermix (Bio-rad) with XIST and GAPDH human specific primers
(see table S1 for primer sequences). Relative XIST gene expression
levels were calculated after they were normalized with expression
levels of GAPDH.
Gene expression analysis by low density arrays
RNA from undifferentiated hESCs were analyzed by a
Taqman based assay, using the human stem cell pluripotency
array (ABI, foster city,CA). Delta Ct values were obtained by
identifying the number of amplification cycles needed to reach the
common threshold (Ct) value for each gene. Then, these values
were normalized by subtraction of the Ct values obtained for a
control gene (beta-Actin) for the same sample. In order to show
that XIST expression variation among the different cell lines is not
due to differentiation in culture, we performed a Brown-Forsthye
test.
SNP analysis
Genomic DNA from the hESC lines was extracted using
DNeasy kit (Qiagene). Due to low amount of starting cells, DNA
for Granulosa cells was extracted with the same kit and was
subjected to whole genome amplification using REPLI-g mini kit
(Qiagene). DNA from CSES1 (p14), CSES8 (p12) and their
corresponding maternal granulosa cells were hybridized to
Affymetrix 250k Sty SNP array (Affymetrix, Santa Clara, CA
http://Affymmetirx.com). The microarray data have been
deposited in GEO and given the series accession number
GSE2167. SNPs were selected for analysis along the X
chromosome according to the following criteria: the gene is X-
linked and expressed in hESCs in moderate to high levels, and the
SNP is heterozygous in the hESC line and homozygous in the
corresponding maternal DNA. Genotype was validated for the
selected SNPs by direct sequencing (see table S1 for primer
sequences). In order to assess the expression from a specific SNP in
CSES1 and CSES8 hESC lines, we used cDNA that was treated
with DNase I as described above to avoid DNA contamination
and amplified the specific regions. Amplicons were separated using
an ethidium bromide stained 2% agarose gel, followed by gel-
purification (Wizard H SV Gel and PCR clean up system, Promega
http://www.promega.com) and direct sequencing reaction to
identify the expressed allele.
Bisulfite genomic sequencing analysis
Genomic DNA samples for CSES1, 2, 3, 5 and 7 were digested
with BglII overnight and treated the following day with sodium
bisulfite for 15 hours as previously described [37]. Converted
DNA samples were cleaned using WizardH DNA Clean Up Kit
(Promega) and were amplified by a single PCR reaction. PCR
products were cloned into the Topo TA Vector 4.0 (Invitrogen).
Individual colonies were picked for sequencing to identify the
allelic methylation patterns. XIST promoter Bisulfite PCR primers
were designed using the MethPrimer online software http://www.
urogene.org/methprimer/index1.html.
Immunocytochemistry and XIST RNA-FISH analysis
Cells for immunostaining were first fixed with 4% PFA/PBS for
20 minutes at room temperature and washed with PBS. Cells were
then permeabilized by 0.4% Triton-X in TBST for 20 min and
blocked in 10% milk and 1% normal goat serum for 1 hour.
Cover slips were incubated 1 hour at room temperature with
primary antibodies diluted in 3% BSA in TBST [monoclonal
mouse anti-OCT4 (1:20, Santa Cruz) and polyclonal rabbit anti-
H3K27me3 (1:1000, a gift from Yi Zhang, University of North
Carolina, Chapel Hill, NC)]. After being washed three times with
PBS, cover slips were incubated in fluorochrome-conjugated
secondary antibodies for 1 hour at room temperature with
protection from light. Hoechst dye #33342 was used to label cell
nuclei. XIST RNA-FISH was performed as described [38] by
using three 50-mer DNA probes designed from consensus
sequences of map positions 6183-6232, 62234-6283 and 6368-
6417 (accession No. L04961), which are in repeat D of XIST.
Supporting Information
Table S1 Primer sequences.
Found at: doi:10.1371/journal.pone.0011330.s001 (0.05 MB
DOC)
XCI in Early Passages of hESCs
PLoS ONE | www.plosone.org 7 June 2010 | Volume 5 | Issue 6 | e11330Figure S1 Percentage of undifferentiated cells positively stained
for H3K27me3. Intermediate state (state II) cells show significant
number of cells with punctate staining for H3K27me3 CSES1 p15
(n=511, 94%), CSES8 p8 (n=257, 87%) CSES10 p15 (n=257,
32%) and CSES11 p12 (n=655, 84%).
Found at: doi:10.1371/journal.pone.0011330.s002 (4.55 MB TIF)
Figure S2 Identical by state (IBS) analysis for CSES1 and its
granulosa cells. Proportion of IBS=0, 0.3% (no shared alleles),
IBS=1, 28% (one shared allele) and IBS=2, 71.7% (two shared
alleles). Overall, 85.7% of the alleles are shared, clearly indicating
for close genetic relationship between the samples.
Found at: doi:10.1371/journal.pone.0011330.s003 (8.34 MB TIF)
Figure S3 SNP sequences for CSES1 samples. SNP rs6620161
shows biallelic expression in p5 with one of the alleles more
prominently expressed. However, in p14 both alleles are expressed
at the same level. rs41537046 shows monoallelic expression at p5,
but at p14 both of the alleles are already expressed. SNP
rs5914796 shows expression of the paternal allele both at p5 and
p14.
Found at: doi:10.1371/journal.pone.0011330.s004 (9.12 MB TIF)
Figure S4 SNP sequences for CSES8 samples. Representing
SNP sequences for CSES8 cell line. SNPs rs1204399, rs42890 and
rs6625472 all show biallelic expression both at p5 and p14.
Found at: doi:10.1371/journal.pone.0011330.s005 (9.24 MB TIF)
Figure S5 Induction of XCI in CSES upon Retinoic Acid
differentiation. XCI detected by immunostaining for H3K27me3
and pluripotency detected by staining for OCT4 were tested in the
three different classes of CSES cells. In CSES2 and CSES7 (A–D),
representing class I cells, we were able to detect induction of XCI
upon differentiation in CSES2 (A, B) but not for CSES7 (C, D).
CSES3 representing class II cells were not able to induce XCI
upon differentiation (E, F). In CSES8, we were able to detect XCI
markers both in the undifferentiated and differentiated cells (G,
H).
Found at: doi:10.1371/journal.pone.0011330.s006 (9.89 MB TIF)
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